Design of Biopolymer-Based Interstitial Therapies for the Treatment of Glioblastoma

Glioblastoma multiforme (GBM) is the most common form of primary brain cancer and has the highest morbidity rate and current treatments result in a bleak 5-year survival rate of 5.6%. Interstitial therapy is one option to increase survival. Drug delivery by interstitial therapy most commonly makes u...

Descripción completa

Detalles Bibliográficos
Autores principales: Pena, Erik S., Graham-Gurysh, Elizabeth G., Bachelder, Eric M., Ainslie, Kristy M.
Formato: Online Artículo Texto
Lenguaje:English
Publicado: MDPI 2021
Materias:
Review
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8658694/
https://www.ncbi.nlm.nih.gov/pubmed/34884965
http://dx.doi.org/10.3390/ijms222313160

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8658694/
https://www.ncbi.nlm.nih.gov/pubmed/34884965
http://dx.doi.org/10.3390/ijms222313160

Ejemplares similares